Spatial epitranscriptomics reveals A-to-I editome specific to cancer stem cell microniches.
Amos Chungwon LeeYongju LeeAhyoun ChoiHan-Byoel LeeKyoungseob ShinHyunho LeeJi Young KimKyung-Min LeeHoe Suk KimSeung Yeon RyuSangeun LeeJong-Ho CheunDuck Kyun YooSumin LeeHansol ChoiTaehoon RyuHuiran YeomNamphil KimJinsung NohYonghee LeeInyoung KimSangwook BaeJinhyun KimWooseok LeeOkju KimYushin JungChanghoe KimSeo Woo SongYeongjae ChoiJunho ChungByung Gee KimWonshik HanSunghoon KwonPublished in: Nature communications (2022)
Epitranscriptomic features, such as single-base RNA editing, are sources of transcript diversity in cancer, but little is understood in terms of their spatial context in the tumour microenvironment. Here, we introduce spatial-histopathological examination-linked epitranscriptomics converged to transcriptomics with sequencing (Select-seq), which isolates regions of interest from immunofluorescence-stained tissue and obtains transcriptomic and epitranscriptomic data. With Select-seq, we analyse the cancer stem cell-like microniches in relation to the tumour microenvironment of triple-negative breast cancer patients. We identify alternative splice variants, perform complementarity-determining region analysis of infiltrating T cells and B cells, and assess adenosine-to-inosine base editing in tumour tissue sections. Especially, in triple-negative breast cancer microniches, adenosine-to-inosine editome specific to different microniche groups is identified.